Saxagliptin: A potential doping agent? A randomized, double-blinded, placebo-controlled, and crossover pilot study in young active men.
Bourdillon N., Eugster P.J., Vocat C., Nguyen T., Wuerzner G., Grouzmann E., Millet G.P., 2022/12. Physiological reports, 10 (23) pp. e15515. Peer-reviewed.